GNH USA

Europe — EMA

Lamivudin/Zidovudin Puren (Zidovudine, Lamivudine)

GNH USA supplies Lamivudin/Zidovudin Puren (Lamivudine/Zidovudine), a nucleoside reverse transcriptase inhibitor for HIV-1 infection treatment.

Zidovudine, Lamivudine

Request sourcing

1
Pack/s

What is Zidovudine, Lamivudine?

Lamivudine/Zidovudine, the active ingredient in Lamivudin/Zidovudin Puren, is a nucleoside reverse transcriptase inhibitor (NRTI) presented as a tablet for oral use. It is employed in the management of HIV‑1 infection in adults and children, typically as part of a combination antiretroviral regimen to suppress viral replication and improve immune function.

GNH USA supplies Lamivudin/Zidovudin Puren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Zidovudine, Lamivudine used for?

Lamivudin/Zidovudin Puren is an antiretroviral medication that targets the HIV replication pathway.

- HIV‑1 infection (adults): suppresses viral replication and increases CD4+ cell counts. - HIV‑1 infection (children): reduces viral load and supports immune development. - HIV‑1 infection (as part of combination therapy): enhances overall treatment efficacy when used with other antiretrovirals.

What are the side effects of Zidovudine, Lamivudine?

Adverse reactions may occur with any antiretroviral regimen.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Headache: transient cranial discomfort. - Fatigue: general tiredness. - Anemia: reduced red blood cell count. - Diarrhea: loose stools. - Neutropenia: lowered neutrophil levels.

Serious or Rare Side Effects: - Severe anemia: may require transfusion. - Lactic acidosis: rare metabolic disturbance. - Hypersensitivity reactions: rash, fever, organ involvement. - Hepatotoxicity: elevated liver enzymes. - Bone marrow suppression: pancytopenia. - Pancreatitis: abdominal pain with elevated enzymes.

What precautions apply to Zidovudine, Lamivudine?

Use of Lamivudin/Zidovudin Puren requires careful clinical monitoring. - Renal function: assess baseline kidney function and monitor periodically. - Hepatic function: evaluate liver enzymes before and during therapy. - Hematologic status: perform regular complete blood counts to detect anemia or neutropenia. - Pregnancy: prescribe only when potential benefits outweigh risks. - Drug resistance: avoid monotherapy to prevent emergence of resistant HIV strains. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

What does Zidovudine, Lamivudine interact with?

Lamivudin/Zidovudin Puren can interact with several concomitant medications.

Major Interactions (Avoid): - Didanosine: increased risk of severe toxicity. - Stavudine: heightened mitochondrial toxicity. - Alcohol: may exacerbate liver injury.

Moderate Interactions (Monitor Closely): - Nephrotoxic drugs: monitor renal parameters. - Anticoagulants (e.g., warfarin): may affect INR levels. - Protease inhibitors: can alter plasma concentrations of lamivudine and zidovudine.

Frequently asked questions

What is Lamivudin/Zidovudin Puren used for?+
Lamivudin/Zidovudin Puren is used as part of combination antiretroviral therapy to treat HIV‑1 infection in both adults and children. It helps lower the viral load and supports immune system recovery when taken under medical supervision.
How does lamivudine and zidovudine work?+
Both lamivudine and zidovudine are nucleoside analogues that, after intracellular activation, mimic natural nucleotides. They are incorporated into the viral DNA by HIV reverse transcriptase, causing premature chain termination and preventing the virus from replicating.
What is the usual dose of Lamivudin/Zidovudin Puren?+
The specific dose and dosing schedule are determined by the prescribing clinician based on the patient’s age, weight, renal and hepatic function, and the overall antiretroviral regimen. Patients should follow the prescriber’s instructions precisely.
Is Lamivudin/Zidovudin Puren safe during pregnancy or breastfeeding?+
Safety in pregnancy and breastfeeding has not been fully established. The medication should only be used if the potential benefits to the mother outweigh any possible risks to the fetus or infant, and this decision must be made by a qualified healthcare professional.
How do I order Lamivudin/Zidovudin Puren from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Lamivudin/Zidovudin compare with other HIV antiretrovirals?+
Lamivudin/Zidovudin combines two nucleoside reverse transcriptase inhibitors, offering a dual mechanism that can simplify regimens compared with using each agent separately. Compared with non‑NRTI classes, it may have a different side‑effect profile and resistance pattern, making it a valuable option in many combination therapies.
What are the storage requirements for Lamivudin/Zidovudin Puren?+
Store the tablets at ambient temperature, below 25 °C, in the original container. Keep them away from moisture, direct sunlight and excessive heat to maintain product stability.
How is Lamivudin/Zidovudin Puren administered?+
The medication is taken orally, usually with or without food, as directed by the prescribing clinician. Swallow the tablet whole with a glass of water and do not crush or split it unless specifically instructed.
What are the most serious risks associated with Lamivudin/Zidovudin Puren?+
Serious risks include severe anemia, lactic acidosis, hypersensitivity reactions, hepatotoxicity, bone‑marrow suppression and pancreatitis. Patients should be monitored regularly for these conditions, and any concerning symptoms should be reported to a healthcare provider immediately.
Who should not use Lamivudin/Zidovudin Puren?+
Individuals with known hypersensitivity to lamivudine, zidovudine, or any excipients in the formulation should avoid this product. It is also contraindicated in patients where monotherapy is planned, as this can promote resistance, and in those with severe pre‑existing anemia or bone‑marrow disorders without close monitoring.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Zidovudine, Lamivudine
Route
Oral Use
Manufacturer
Puren Pharma Gmbh & Co. Kg
Origin
EU

Related products

Combivir

Combivir

Zidovudine, Lamivudine

Viiv Healthcare B.V.
EU
Combivir

Combivir

Zidovudine, Lamivudine

Viiv Healthcare B.V.
EU
Combivir

Combivir

Zidovudine, Lamivudine

Viiv Healthcare B.V.
EU
Combivir

Combivir

Zidovudine, Lamivudine

Viiv Healthcare B.V.
EU